Abstracts tagged "musculoskeletal disorders and pediatric rheumatology"

Abstract Number: 2182 • 2013 ACR/ARHP Annual Meeting
Spectrum Of Musculoskeletal Inpatient Diagnoses At The Largest Pediatric Center In East Africa In 2011
Angela Migowa¹, Ines Colmegna², Evelyne Ng'ang'a³, John Wachira⁴, Thomas Ngwiri⁵, Carol A. Hitchon⁶, Sasha Bernatsky⁷ and Rosie Scuccimarri⁸, ¹Pediatrics, Aga Khan University Hospital, Nairobi, Kenya, ²Rheumatology, McGill University Health Centre, Montreal, QC, Canada, ³Pediatrics, University of Nairobi, Nairobi, Kenya, ⁴Pediatrics, Gertrude's Children Hospital, Nairobi, Kenya, ⁵Pediatrics, Gertrude's Children's Hospital, Nairobi, Kenya, ⁶Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ⁷Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, ⁸McGill University, Montreal, QC, Canada
Background/Purpose: Pediatric rheumatic diseases are among the most common chronic illnesses of childhood and can cause considerable disease burden and disability. The frequency and outcomes…
Abstract Number: 2183 • 2013 ACR/ARHP Annual Meeting
Spectrum Of Outpatient Musculoskeletal Visits At The Largest Pediatric Center In East Africa In 2011
Laurel Broten¹, Angela Migowa², Rosie Scuccimarri³, Evelyne Ng'ang'a⁴, John Wachira⁵, Thomas Ngwiri⁶, Sasha Bernatsky⁷, Carol A. Hitchon⁸ and Ines Colmegna⁹, ¹Rheumatology, McGill University, Montreal, QC, Canada, ²Pediatrics, Aga Khan University Hospital, Nairobi, Kenya, ³McGill University, Montreal, QC, Canada, ⁴Pediatrics, University of Nairobi, Nairobi, Kenya, ⁵Pediatrics, Gertrude's Children Hospital, Nairobi, Kenya, ⁶Pediatrics, Gertrude's Children's Hospital, Nairobi, Kenya, ⁷Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, ⁸Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ⁹Rheumatology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Pediatric rheumatic diseases are a major cause of morbidity, frequently leading to permanent disability, impaired functional status and quality of life, and significant direct…
Abstract Number: 2089 • 2013 ACR/ARHP Annual Meeting
Downregulation Of Mir-10a Is Associated With Increased Von Willebrand Factor Antigen, Disease Activity Score and Earlier Diagnosis In Children With Untreated Juvenile Dermatomyositis
Dong Xu^1,2, Akadia Kachaochana¹, Gabrielle A. Morgan³, Chiang-Ching Huang⁴ and Lauren M. Pachman^2,3, ¹Program of Excellence in Cure-Juvenile Myositis (JM) Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, ²Division of Pediatric Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ³Cure JM Myositis Center, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Chicago, IL, ⁴Zilber School of Public Health, University of Wisconsin at Milwaukee, Milwaukee, WI
Background/Purpose: We previously reported (Arthritis Rheum 2012;64 Suppl 10:1670) that miRNA array studies of diagnostic muscle biopsies obtained from untreated children with Juvenile Dermatomyositis (JDM)…
Abstract Number: 228 • 2013 ACR/ARHP Annual Meeting
The Composition and Structure Of Calcifications In Juvenile Dermatomyositis Differs From Calcified Aortic Valves Removed From Adults Without JDM
Lauren M. Pachman^1,2, Gabrielle A. Morgan¹, Patrick M. McCarthy³, Anna Huskin³, S. Chris Malaisrie³, Lyudmila Spevak⁴, Stephen Doty⁴ and Adele Boskey⁴, ¹Cure JM Myositis Center, Ann & Robert H. Lurie Children's Hospital of Chicago Research Center, Chicago, IL, ²Division of Pediatric Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ³Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute, Chicago, IL, ⁴Hospital for Special Surgery, New York, NY
Background/Purpose: Juvenile Dermatomyositis (JDM) is a systemic vasculopathy, primarily involving the micro vasculature. Soft tissue calcification occurs in 15-30% of cases, and is associated with…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].